Intracranial Gliomas Part III - Innovative Treatment Modalities

Editor(s): Chernov, Mikhail F. (Tokyo)
Muragaki, Yoshihiro (Tokyo)
Kesari, Santosh (Santa Monica, CA)
McCutcheon, Ian E. (Houston, TX)
 

Convection-Enhanced Delivery for Management of Malignant Gliomas

Prabhu S.S.

Author affiliations

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Related Articles for ""

Chernov MF, Muragaki Y, Kesari S, McCutcheon IE (eds): Intracranial Gliomas. Part III - Innovative Treatment Modalities. Prog Neurol Surg. Basel, Karger, 2018, vol 32, pp 152-158

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: July 10, 2018
Cover Date: 2018

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 0

ISBN: 978-3-318-06062-1 (Print)
eISBN: 978-3-318-06063-8 (Online)

Abstract

Convection-enhanced delivery (CED) is a novel method of bypassing the blood-brain barrier for administration of therapeutic agents directly into brain with a potential to provide concentrations that cannot be achieved with systemic drug delivery. This technique has grown significantly over the last 20 years with better understanding of the biomechanics of infusion and of the delivery process. Though clinical trials of CED in malignant brain tumors have not yielded the desired results, a number of new biologically active compounds and pharmaceutical preparations, their carriers, modes of delivery, and improved catheter designs are continually being tested, which hold promise for the future.

© 2018 S. Karger AG, Basel




Related Articles:


References

  1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
  2. Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E: A population-based study of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001;51:100-107.
  3. Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M: Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994;30:146-149.
  4. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-1018.
  5. Muldoon LL, Soussain C, Jahnke K, Johanson C, Siegal T, Smith QR, Hall WA, Hynynen K, Senter PD, Peereboom DM, Neuwelt EA: Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol 2007;25:2295-2305.
  6. Levin VA: A pharmacologic basis for brain tumor chemotherapy. Semin Oncol 1975;2:57-61.
  7. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 1994;91:2076-2080.
  8. Prabhu SS, Broaddus WC, Gillies GT, Loudon WG, Chen ZJ, Smith B: Distribution of macromolecular dyes in brain using positive pressure infusion: a model for direct controlled delivery of therapeutic agents. Surg Neurol 1998;50:367-375.
  9. Walstra G, Takagi H, Marmarou A, Shapiro K, Shulman K: The time course of brain tissue compliance and resistance in a controlled model of brain edema; in Shulman K, Marmarou A, Miller JD, Becker DP, Hochwald GM, Brock M (eds): Intracranial Pressure IV. Berlin, Springer-Verlag, 1980, pp 253-256.
  10. Marmarou A, Tanaka K, Shulman K: The brain response to infusion edema: dynamics of fluid resolution; in Hartmann A, Brock M (eds): Treatment of Cerebral Edema. Berlin, Springer-Verlag, 1982, pp 11-18.
  11. Marmarou A, Hochwald G, Nakamura T, Tanaka K, Weaver J, Dunbar J: Brain edema resolution by CSF pathways and brain vasculature in cats. Am J Physiol 1994;267(2 pt 2):H514-H520.
  12. Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH: Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 1999;90:315-320.
  13. Chen ZJ, Gillies GT, Broaddus WC, Prabhu SS, Fillmore H, Mitchell RM, Corwin FD, Fatouros PP: A realistic brain tissue phantom for intraparenchymal infusion studies. J Neurosurg 2004;101:314-322.
  14. Haar PJ, Chen ZJ, Fatouros PP, Gillies GT, Corwin FD, Broaddus WC: Modelling convection-enhanced delivery in normal and oedematous brain. J Med Eng Technol 2014;38:76-84.
  15. Debinski W, Tatter SB: Convection-enhanced delivery for the treatment of brain tumors. Expert Rev Neurother 2009;9:1519-1527.
  16. Bernal GM, LaRiviere MJ, Mansour N, Pytel P, Cahill KE, Voce DJ, Kang S, Spretz R, Welp U, Noriega SE, Nuñez L, Larsen G, Weichselbaum RR, Yamini B: Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine 2014;10:149-157.
  17. Brady ML, Raghavan R, Singh D, Anand PJ, Fleisher AS, Mata J, Broaddus WC, Olbricht WL: In vivo performance of a microfabricated catheter for intraparenchymal delivery. J Neurosci Methods 2014;229:76-83.
  18. Lewis GK Jr, Schulz ZR, Pannullo SC, Southard TL, Olbricht WL: Ultrasound-assisted convection-enhanced delivery to the brain in vivo with a novel transducer cannula assembly. J Neurosurg 2012;117:1128-1140.
  19. Sampson JH, Brady M, Raghavan R, Mehta AI, Friedman AH, Reardon DA, Petry NA, Barboriak DP, Wong TZ, Zalutsky MR, Lally-Goss D, Bigner DD: Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans. Neurosurgery 2011;69:668-676.
  20. Asthagiri AR, Walbridge S, Heiss JD, Lonser RR: Effect of concentration on the accuracy of convective imaging distribution of a gadolinium-based surrogate tracer. J Neurosurg 2011;115:467-473.
  21. Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK: Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 2010;12:871-881.
  22. Mueller S, Polley MY, Lee B, Kunwar S, Pedain C, Wembacher-Schröder E, Mittermeyer S, Westphal M, Sampson JH, Vogelbaum MA, Croteau D, Chang SM: Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study. J Neurooncol 2011;101:267-277.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: July 10, 2018
Cover Date: 2018

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 0

ISBN: 978-3-318-06062-1 (Print)
eISBN: 978-3-318-06063-8 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP